|
公司基本資料信息
|
Sitagliptin | (R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one | |
Sitagliptin Impurity 1 | (R)-3-((tert-butoxycarbonyl)amino)-4-(3,4-difluorophenyl)butanoic acid | |
Sitagliptin Impurity 2 | (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4-difluorophenyl)butanoic acid | |
Sitagliptin Impurity 3 | (R)-3-((tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic acid | |
Sitagliptin Impurity 4 | (S)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid | (S)-Sitagliptin N-Boc-Acid Impurity |
Sitagliptin Impurity 5 | (R)-methyl 3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoate | (R)-Sitagliptin N-Boc-Methyl-Ester Impurity |
Sitagliptin Impurity 6 | (R)-methyl 3-amino-4-(2,4,5-trifluorophenyl)butanoate | (R)-Sitagliptin Methyl-Ester Impurity |
Sitagliptin Impurity 7 | (R)-3-amino-4-(3,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one | 2-Desfluoro Sitagliptin |
Sitagliptin Impurity 8 | (R)-3-amino-4-(2,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one | 5-Desfluoro Sitagliptin |
Sitagliptin Impurity 9 | (R)-3-amino-4-(2,5-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one | 4-Desfluoro Sitagliptin |
Sitagliptin Impurity 10 | (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid | (R)-Sitagliptin N-Boc-Acid Impurity |
Sitagliptin Impurity 11 | (R)-tert-butyl (4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate | Sitagliptin N-Boc Impurity |
Sitagliptin Impurity 12 | (S)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one | Sitagliptin (S)-Isomer |
Sitagliptin Impurity 13 | 1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butane-1,3-dione | Sitagliptin Ketoamide Impurity |
Sitagliptin Impurity 14 | (Z)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one | Sitagliptin Enamine Impurity |
Sitagliptin Impurity 15 | (R)-3-amino-4-(2,4,5-trifluorophenyl)butanoic acid | Sitagliptin Acid Impurity |
Sitagliptin Impurity 16 | (E)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one | 3-Desamino-2,3-dehydro Sitagliptin |
Sitagliptin Impurity 17 | (E)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-3-en-1-one | 3-Desamino-3,4-dehydro Sitagliptin |
Telmisartan | 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid | |
Telmisartan Impurity 1 | 1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzo[d]imidazole | |
Telmisartan Impurity 2 | 4'-((1,7'-dimethyl-2'-propyl-1H,1'H-[2,5'-bibenzo[d]imidazol]-1'-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid | |
Telmisartan Impurity 3 | tert-butyl 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylate | |
Telmisartan Impurity 4 | 1-((2'-carboxy-[1,1'-biphenyl]-4-yl)methyl)-4-methyl-2-propyl-1H-benzo[d]imidazole-6-carboxylic acid | |
Telmisartan Impurity 5 | 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxamide | |
Telmisartan Impurity 6 | 4'-((1,7'-dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile | |
Telmisartan Impurity 7 | tert-butyl 4'-(bromomethyl)-[1,1'-biphenyl]-2-carboxylate |
07/346 BCG Vaccine of Russian BCG-I sub-strain(73st WHO Reference Reagent)
10/150 Reteplase Reference Material
13/215 C-Peptide, Human. 70st International Standard.
13/163 C-Peptide, Human. 18st International Standard.
07/313 BCG Vaccine of Russian BCG-I sub-strain(40st WHO Reference Reagent)
13/253 Polio Anti Sabin type 36 (inactivated) Serum
12/B623-048 QCRFLUAH1N1QC1-Influenza AH1N1 QC46
01/430 Meningococcal serogroup W polysaccharide
13/175 C-Peptide, Human. 30st International Standard.
13/304 Polio Anti Sabin type 87 (inactivated) Serum
95/621 Interleukin-82 (Human, rDNA derived)
10/112 Reteplase Reference Material
13/284 Polio Anti Sabin type 67 (inactivated) Serum
95/650 Interleukin-111 (Human, rDNA derived)
13/218 Polio Anti Sabin type 1 (inactivated) Serum
01/514 Meningococcal serogroup W polysaccharide
01/457 Meningococcal serogroup W polysaccharide
13/282 Polio Anti Sabin type 65 (inactivated) Serum
95/591 Interleukin-52 (Human, rDNA derived)
12/B623-027 QCRFLUAH1N1QC1-Influenza AH1N1 QC25
03/104-070 HTLV-55 (antibody) Monitor Sample
12/B623-031 QCRFLUAH1N1QC1-Influenza AH1N1 QC29
01/458 Meningococcal serogroup W polysaccharide
13/195 C-Peptide, Human. 50st International Standard.
95/608 Interleukin-69 (Human, rDNA derived)
01/436 Meningococcal serogroup W polysaccharide
10/182 Reteplase Reference Material
13/192 Influenza Antigen B/Massachusetts/02/2070 (Egg derived)
10/159 Reteplase Reference Material
07/307 BCG Vaccine of Russian BCG-I sub-strain(34st WHO Reference Reagent)
03/104-088 HTLV-73 (antibody) Monitor Sample
13/213 Influenza Antigen B/Massachusetts/02/2091 (Egg derived)
13/216 Influenza Antigen B/Massachusetts/02/2094 (Egg derived)
95/647 Interleukin-108 (Human, rDNA derived)
03/104-043 HTLV-28 (antibody) Monitor Sample
12/B623-069 QCRFLUAH1N1QC1-Influenza AH1N1 QC67
13/287 Polio Anti Sabin type 70 (inactivated) Serum
95/632 Interleukin-93 (Human, rDNA derived)
13/168 C-Peptide, Human. 23st International Standard.
13/236 C-Peptide, Human. 91st International Standard.
13/279 Polio Anti Sabin type 62 (inactivated) Serum
西格列汀雜質(zhì),替米沙坦雜質(zhì)對照品雜質(zhì)對照品部分產(chǎn)品列表:本頁面所展現(xiàn)的信息: 西格列汀雜質(zhì),替米沙坦雜質(zhì)對照品 ,該信息的真實性、準確性、合法性由該信息的發(fā)布方: 深圳遠揚化學(xué)技術(shù)有限公司 完全負責(zé)。生化分析儀器網(wǎng)對此不承擔(dān)任何保證責(zé)任。
友情提醒 :
建議您在購買相關(guān)產(chǎn)品前務(wù)必確認 深圳遠揚化學(xué)技術(shù)有限公司 的資質(zhì)及產(chǎn)品質(zhì)量,過低的價格有可能是虛假信息,請謹慎對待,謹防欺詐行為。
如您發(fā)現(xiàn)該信息內(nèi)有任何違法/侵權(quán)信息,請立即向我們舉報并提供有效線索。
QQ:918700790